Clinical Trial Update: A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study to evaluate the safety and efficacy of TG-C in subjects with symptomatic early hip osteoarthritis. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Osteoarthritis
• Osteoarthritis

Drugs mentioned

• TG-C (tissueGene-C)

Snippet

Sponsor: Kolon TissueGene, Inc. | Conditions: Degenerative Osteoarthritis | Phase 2 | Status: NOT_YET_RECRUITING